Get started
Author

Martina Nibbio

Observed name: M. Nibbio
Institution: IRBM
ORCID: 0000-0002-2905-3689
Observed ORCID: 0000-0002-2905-3689
OpenAlex ID: A5003336792
Imaging Mutant Huntingtin Aggregates: Development of a Potential PET Ligand
2020 · Longbin Liu, Michael E. Prime, et al. · Journal of Medicinal Chemistry · 46
Discovery and Characterization of Novel Anti-schistosomal Properties of the Anti-anginal Drug, Perhexiline and Its Impact on Schistosoma mansoni Male and Female Reproductive Systems
2016 · Alessandra Guidi, Cristiana Lalli, et al. · PLoS neglected tropical diseases · 29
PDF
Discovery of a Novel Series of Imidazopyrazine Derivatives as Potent SHP2 Allosteric Inhibitors
2023 · Esther Torrente, Valentina Fodale, et al. · ACS Medicinal Chemistry Letters · 27
PDF
[11C]CHDI-626, a PET Tracer Candidate for Imaging Mutant Huntingtin Aggregates with Reduced Binding to AD Pathological Proteins
2021 · Longbin Liu, Peter D. Johnson, et al. · Journal of Medicinal Chemistry · 27
Use of ‘dilute-and-shoot’ liquid chromatography-high resolution mass spectrometry in preclinical research: application to a DMPK study of perhexiline in mouse plasma
2015 · Simone Esposito, Elena Bracacel, et al. · Journal of Pharmaceutical and Biomedical Analysis · 19
Structure–activity relationship and properties optimization of a series of Quinazoline-2,4-diones as inhibitors of the canonical Wnt pathway
2015 · Arianna Nencini, Carmela Pratelli, et al. · European Journal of Medicinal Chemistry · 19
Discovery of a Novel Series of Potent SHP2 Allosteric Inhibitors
2023 · Alessia Petrocchi, Alessandro Grillo, et al. · ACS Medicinal Chemistry Letters · 16
PDF
5,6-Dihydroxypyrimidine Scaffold to Target HIV-1 Nucleocapsid Protein
2020 · Savina Malancona, Mattia Mori, et al. · ACS Medicinal Chemistry Letters · 10
An allosteric inhibitor of the Zika virus NS2B-NS3 protease with oral efficacy in mouse models
2026 · Jesus M. Ontoria, Esther Torrente, et al. · Nature Communications · 6
PDF
Brain penetration assessment in vivo: A reliable and simple method in anesthetized rats at steady state
2014 · Claus A. Andersen, Paolo Perfetti, et al. · Journal of Neuroscience Methods · 5
Identification and in vitro characterization of a new series of potent and highly selective G9a inhibitors as novel anti-fibroadipogenic agents
2022 · Pietro Randazzo, Roberta Sinisi, et al. · Bioorganic & Medicinal Chemistry Letters · 4
Novel azabicyclic series of potent SHP2 allosteric inhibitors
2025 · Alessio Sferrazza, Ilaria Rossetti, et al. · Bioorganic & Medicinal Chemistry Letters · 2
Discovery and Preclinical Characterization of I-0436650, a Selective SHP2 Allosteric Inhibitor for RAS-Driven Cancers
2026 · Alina Ciammaichella, Francesca Puca, et al. · Journal of Medicinal Chemistry
Abstract 5614: Advancing treatment for brain tumors and metastases with brain permeable SHP2 inhibitor I-1000233
2025 · Francesca Puca, Alina Ciammaichella, et al. · Cancer Research
Abstract 1975: Discovery of I-1000233, a potent, selective and brain permeable SHP2 allosteric inhibitor
2024 · Francesca Puca, Danilo Fabbrini, et al. · Cancer Research
Discovery of I-0436650, a potent and selective SHP2 allosteric inhibitor for the treatment of RAS driven solid tumors
2022 · F. Puca, V. Fodale, et al. · European Journal of Cancer
PDF
Works count: 16
Citation count: 210
H-index: 8
I10-index: 8
Year
Topic
Type